Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Foghorn Therapeutics Inc. - Common Stock (NQ:FHTX)

4.231 -0.139 (-3.18%)
Streaming Delayed Price Updated: 11:38 AM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Foghorn Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Foghorn Therapeutics Highlights Recent Clinical and Research Progress and Provides Strategic Objectives for 2023
From Foghorn Therapeutics, Inc.
Via GlobeNewswire
News headline image
Foghorn Therapeutics Announces New Preclinical Data for FHD-286 in AML to Be Presented at the American Society of Hematology Annual Meeting
From Foghorn Therapeutics, Inc.
Via GlobeNewswire
News headline image
Foghorn Therapeutics to Participate at the Evercore ISI HealthCONx Conference
From Foghorn Therapeutics, Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
News headline image
4 Analysts Have This to Say About Foghorn Therapeutics ↗
  Analysts have provided the following ratings for Foghorn Therapeutics (NASDAQ:FHTX) within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  During Wednesday's session, 107 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Foghorn Therapeutics to Present at Connective Tissue Oncology Society Annual Meeting
From Foghorn Therapeutics, Inc.
Via GlobeNewswire
News headline image
Foghorn Therapeutics to Present New Preclinical Data for BRG1/BRM Inhibitor FHD-286 in Combination with Anti-PD-1 Antibody at Society for Immunotherapy of Cancer 37th Annual Meeting
From Foghorn Therapeutics, Inc.
Via GlobeNewswire
News headline image
Foghorn Therapeutics Provides Third Quarter 2022 Financial and Corporate Update
From Foghorn Therapeutics, Inc.
Via GlobeNewswire
News headline image
Foghorn Therapeutics Appoints Dr. Thomas J. Lynch, Jr. to Its Board of Directors
From Foghorn Therapeutics, Inc.
Via GlobeNewswire
News headline image
Foghorn Therapeutics Announces New Data Demonstrating BRD9 Degradation in Patient Tumor Biopsies and Discloses New Selective CBP Program
From Foghorn Therapeutics, Inc.
Via GlobeNewswire
News headline image
Foghorn Therapeutics to Present at Hanson Wade's 5th Annual Targeted Protein Degradation Summit
From Foghorn Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2022 ↗
  
Via Benzinga
News headline image
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday ↗
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday. 
Via Benzinga
News headline image
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
Dow Drops Over 100 Points; Aerie Pharmaceuticals Shares Spike Higher ↗
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 100 points on Tuesday. 
Via Benzinga
News headline image
Twitter, Zoom Video And Some Other Big Stocks Moving Lower On Tuesday ↗
  GigaCloud Technology Inc. (NASDAQ: GCT) fell 29.9% to $29.01 after declining around 14% on Monday. 
Via Benzinga
News headline image
Nasdaq Turns Lower; Crude Oil Rises Sharply ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite turning negative on Tuesday. 
Via Benzinga
News headline image
US Stocks Mixed; Dow Falls 50 Points ↗
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 50 points on Tuesday. 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Nasdaq Gains 150 Points; Copper Up 1.5% ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 600 points on Monday. 
Via Benzinga
News headline image
Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Mid-Day Market Update: Dow Rises Over 600 Points; O2Micro International Shares Surge ↗
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 600 points on Monday. 
Via Benzinga
News headline image
58 Biggest Movers From Yesterday ↗
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million. 
Via Benzinga
News headline image
30 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday. 
Via Benzinga
News headline image
66 Biggest Movers From Friday ↗
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year. 
Via Benzinga
News headline image
Mid-Day Market Update: Dow Tumbles 200 Points; TherapeuticsMD Shares Jump ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 200 points on Friday. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.